Bioxcel Therap
BTAI0.86061.53% ( +0.0130 )
Bioxcel Therap (BTAI)
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intellige...
- Open
- 0.8600
- High
- 0.8900
- Low
- 0.8600
- Prev. Close
- 0.8476
- Volume
- 457.45K
- Turnover
- 400.36K
- Avg Price
- 0.8752
- Bid/Ask Ratio
- --
- Amplitude
- 3.54%
- 52wk High
- 8.0800
- Volume Ratio
- 1.61
- Turnover Ratio
- 1.74%
Bioxcel Therap Analyst Rating
View MoreForecast & Rating
May 15, 2026Price forecast
$14.001526.77%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell25.00%
News
- PUBT · 2 days ago, 06:03 AM
BioXcel Therapeutics amends Oaktree-led credit agreement, defers loan payment to Aug. 31
- benzinga_article · Jul 14 at 12:05 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga_article · Jul 8 at 12:05 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga_article · Jul 6 at 12:05 PM
12 Health Care Stocks Moving In Monday's Intraday Session
- Tip Ranks · Jul 6 at 05:32 AM
BioXcel Therapeutics Amends Credit Agreement, Tightens Liquidity
- PUBT · Jul 6 at 05:07 AM
BioXcel Therapeutics forms strategic committee to weigh restructuring, bankruptcy options under Oaktree loan amendment
